Perbedaan UBC Medical Indonesia Tbk. dan Multi Indocitra Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Multi Indocitra Tbk. diperdagangkan di Rp520 (kapitalisasi pasar 312 M, volume 24 jam 100). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2× kapitalisasi pasar Multi Indocitra Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 100). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | MICE | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 312 M |
Volume | 843 rb | 100 |
Lot | 8,43 rb | 1 |
Perputaran | 137,6 jt | 52 rb |
Harga Rata-rata | 163,22 | 520 |
Nilai Transaksi | 137,6 jt | 52 rb |
Harga Ekuilibrium Indikatif | 165 | — |
Volume Ekuilibrium Indikatif | 246 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Selengkapnya di halaman MICE →